Cargando…

PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study

The treatment of diseases that affect the central nervous system (CNS) represents a great research challenge due to the restriction imposed by the blood–brain barrier (BBB) to allow the passage of drugs into the brain. However, the use of modified nanomedicines engineered with different ligands that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoyos-Ceballos, Gina P., Ruozi, Barbara, Ottonelli, Ilaria, Da Ros, Federica, Vandelli, Maria Angela, Forni, Flavio, Daini, Eleonora, Vilella, Antonietta, Zoli, Michele, Tosi, Giovanni, Duskey, Jason T., López-Osorio, Betty L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023215/ https://www.ncbi.nlm.nih.gov/pubmed/31963430 http://dx.doi.org/10.3390/pharmaceutics12010072

Ejemplares similares

Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications
por: Duskey, Jason Thomas, et al.
Publicado: (2020)

Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
por: Vilella, Antonietta, et al.
Publicado: (2015)

Tween(®) Preserves Enzyme Activity and Stability in PLGA Nanoparticles
por: Duskey, Jason Thomas, et al.
Publicado: (2021)

Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function
por: Duskey, Jason Thomas, et al.
Publicado: (2020)

Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
por: Pederzoli, Francesca, et al.
Publicado: (2019)

Tunneling Nanotubes: A New Target for Nanomedicine?
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles
por: Rigon, Laura, et al.
Publicado: (2019)

Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization
por: Rodà, Francesca, et al.
Publicado: (2023)

Quantitative comparison of the protein corona of nanoparticles with different matrices
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136]
por: Ottonelli, Ilaria, et al.
Publicado: (2023)

Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
por: Oddone, Natalia, et al.
Publicado: (2020)

Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Microfluidic Technology for the Production of Hybrid Nanomedicines
por: Ottonelli, Ilaria, et al.
Publicado: (2021)

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
por: Duskey, Jason Thomas, et al.
Publicado: (2022)

Assessment of the Effect of PLGA Co-polymers and PEG on the Formation and Characteristics of PLGA-PEG-PLGA Co-block Polymer Using Statistical Approach
por: Sulaiman, Teuku Nanda Saifullah, et al.
Publicado: (2019)

DPD simulations on morphologies and structures of blank PLGA-b-PEG-b-PLGA polymeric micelles and docetaxel-loaded PLGA-b-PEG-b-PLGA polymeric micelles
por: Wang, Mengyao, et al.
Publicado: (2022)

PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023)

AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study
por: Ruozi, Barbara, et al.
Publicado: (2011)

Thermosensitive PLGA–PEG–PLGA Hydrogel as Depot Matrix for Allergen-Specific Immunotherapy
por: Heine, Sonja, et al.
Publicado: (2022)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
por: Rafiei, Pedram, et al.
Publicado: (2017)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020)

Reduced Cardiotoxicity of Ponatinib-Loaded PLGA-PEG-PLGA Nanoparticles in Zebrafish Xenograft Model
por: Al-Thani, Hissa F., et al.
Publicado: (2022)

“Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury
por: Moretti, Marzia, et al.
Publicado: (2023)

Drug-loaded PEG-PLGA nanoparticles for cancer treatment
por: Zhang, Dan, et al.
Publicado: (2022)

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
por: Rezaeian Shiadeh, Seyedeh Nesa, et al.
Publicado: (2023)

Development of Novel Zn(2+) Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences
por: Grabrucker, Andreas M., et al.
Publicado: (2011)

Neuroprotective effect of insulin-loaded chitosan nanoparticles/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats
por: Rong, Xianfang, et al.
Publicado: (2018)

Investigating a Curcumin-Loaded PLGA-PEG-PLGA Thermo-Sensitive Hydrogel for the Prevention of Alzheimer’s Disease
por: Lin, Yi-Wen, et al.
Publicado: (2022)

Process analytical technology as in-process control tool in semi-continuous manufacturing of PLGA/PEG-PLGA microspheres
por: Anwar, Arfidin, et al.
Publicado: (2023)

Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
por: Hu, Sanyuan, et al.
Publicado: (2010)

Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells
por: Zhang, Bokai, et al.
Publicado: (2017)

Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice
por: Daini, Eleonora, et al.
Publicado: (2023)

Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy
por: Pascolo, Lorella, et al.
Publicado: (2014)

Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
por: Rinaldi, Arianna, et al.
Publicado: (2022)

A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide
por: Paulino da Silva Filho, Omar, et al.
Publicado: (2021)

Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
por: Aggarwal, Sahil, et al.
Publicado: (2013)

A Tailored Thermosensitive PLGA-PEG-PLGA/Emulsomes Composite for Enhanced Oxcarbazepine Brain Delivery via the Nasal Route
por: El-Zaafarany, Ghada M., et al.
Publicado: (2018)

Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine
por: Gao, Ying, et al.
Publicado: (2020)

Doxorubicin and CD-CUR inclusion complex co-loaded in thermosensitive hydrogel PLGA-PEG-PLGA localized administration for osteosarcoma
por: Yang, Zhiming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fi80ckj45ff7fs64rlb14v0hqe